Journal Article

CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis

Rayjean J. Hung, Paolo Boffetta, Jürgen Brockmöller, Dorota Butkiewicz, Ingolf Cascorbi, Margie L. Clapper, Seymour Garte, Aage Haugen, Ari Hirvonen, Sisko Anttila, Ivan Kalina, Loïc Le Marchand, Stephanie J. London, Agneta Rannug, Marjorie Romkes, Jan Salagovic, Bernadette Schoket, Laura Gaspari and Emanuela Taioli

in Carcinogenesis

Volume 24, issue 5, pages 875-882
Published in print May 2003 | ISSN: 0143-3334
Published online May 2003 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgg026
CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Polymorphisms for genes encoding the metabolic enzymes cytochrome P450 1A1 (CYP1A1) and glutathione S-transferase M1 (GSTM1) might contribute to the variability in individual susceptibility to lung cancer. The role of CYP1A1 and GSTM1 in lung carcinogenesis might be more important at low levels of exposure to carcinogens. Non-smokers represent a population at low exposure, however, they are often overlooked because of the small number of cases. We therefore conducted a pooled analysis of 14 case–control studies on lung cancer in Caucasian non-smokers with comparable information on genetic polymorphisms included in the International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens. We pooled the raw data from a total of 302 cases and 1631 controls with random effects models. We also evaluated the possibility of inclusion bias and conducted influence analyses. The odds ratio (OR) of lung cancer for the variant CYP1A1 Ile462Val polymorphism (Ile/Val, Val/Val) was 2.99 [95% confidence interval (95%CI) 1.51–5.91]; this effect was stronger on lung adenocarcinoma (OR 4.85, 95%CI 2.03–11.6). After excluding outlying or imprecise studies, we did not observe a significant effect of the CYP1A1 MspI (T3801C) polymorphism or GSTM1 null genotype (OR 1.20, 95%CI 0.89–1.63). Furthermore, our analyses suggested a combined effect of the CYP1A1 Ile462Val polymorphism and GSTM1 null genotype. The OR for the combination of the CYP1A1 Ile462Val variant and GSTM1 null genotype was 4.67 (95%CI 2.00–10.9) compared with the concurrent presence of the CYP1A1 wild-type and GSTM1 non-null genotype. We did not observe a modification of the effect of the GSTM1 null genotype according to exposure to environmental tobacco smoke and urban/rural residence. Our study therefore suggests that the CYP1A1 Ile462Val variant allele might play a role in lung carcinogenesis among non-smokers, possibly in combination with the GSTM1 null genotype.

Keywords: 95%CI, 95% confidence interval; ETS, environmental tobacco smoke; GSEC, International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens; OR, odds ratio; PAH, polycyclic aromatic hydrocarbon.

Journal Article.  6426 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.